Literature DB >> 25637191

Proceedings: moving toward cell-based therapies for liver disease.

Lisa C Kadyk1, Lila R Collins2, Neil J Littman2, Maria T Millan2.   

Abstract

Despite available medical therapy and organ transplantation, a significant unmet medical need remains for the treatment of liver failure, end-stage liver disease, and liver-based inborn errors of metabolism. Liver cell transplantation has the potential to address this need; however, the field is in search of a suitable cell therapeutic. The ability to reproducibly generate a well-characterized source of engraftable and functional liver cells has continued to be a challenge. Recent progress with tissue-derived stem/progenitor cells and pluripotent stem cell-derived cells now offers the field the opportunity to address this challenge. ©AlphaMed Press.

Entities:  

Mesh:

Year:  2015        PMID: 25637191      PMCID: PMC4339855          DOI: 10.5966/sctm.2014-0276

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  13 in total

Review 1.  Cell therapies for liver diseases.

Authors:  Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

Review 2.  Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas.

Authors:  James E Everhart; Constance E Ruhl
Journal:  Gastroenterology       Date:  2009-02-24       Impact factor: 22.682

Review 3.  Major challenges limiting liver transplantation in the United States.

Authors:  J A Wertheim; H Petrowsky; S Saab; J W Kupiec-Weglinski; R W Busuttil
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

4.  Vascularized and functional human liver from an iPSC-derived organ bud transplant.

Authors:  Takanori Takebe; Keisuke Sekine; Masahiro Enomura; Hiroyuki Koike; Masaki Kimura; Takunori Ogaeri; Ran-Ran Zhang; Yasuharu Ueno; Yun-Wen Zheng; Naoto Koike; Shinsuke Aoyama; Yasuhisa Adachi; Hideki Taniguchi
Journal:  Nature       Date:  2013-07-03       Impact factor: 49.962

Review 5.  Human hepatocyte transplantation: worldwide results.

Authors:  Robert A Fisher; Stephen C Strom
Journal:  Transplantation       Date:  2006-08-27       Impact factor: 4.939

6.  Differentiation and characterization of metabolically functioning hepatocytes from human embryonic stem cells.

Authors:  Yuyou Duan; Xiaocui Ma; Xiaochui Ma; Wei Zou; Charles Wang; Iman Saramipoor Bahbahan; Tijess P Ahuja; Vladimir Tolstikov; Mark A Zern
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

7.  Hepatic differentiation of amniotic epithelial cells.

Authors:  Fabio Marongiu; Roberto Gramignoli; Kenneth Dorko; Toshio Miki; Aarati R Ranade; Maria Paola Serra; Silvia Doratiotto; Marcella Sini; Shringi Sharma; Keitaro Mitamura; Tiffany L Sellaro; Veysel Tahan; Kristen J Skvorak; Ewa C S Ellis; Stephen F Badylak; Julio C Davila; Ronald Hines; Ezio Laconi; Stephen C Strom
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

Review 8.  Cellular therapy for liver disease.

Authors:  Robert C Huebert; Jorge Rakela
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

9.  Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells.

Authors:  Xiaocui Ma; Yuyou Duan; Benjamin Tschudy-Seney; Garrett Roll; Iman Saramipoor Behbahan; Tijess P Ahuja; Vladimir Tolstikov; Charles Wang; Jeannine McGee; Shiva Khoobyari; Jan A Nolta; Holger Willenbring; Mark A Zern
Journal:  Stem Cells Transl Med       Date:  2013-05-16       Impact factor: 6.940

10.  Mouse liver repopulation with hepatocytes generated from human fibroblasts.

Authors:  Saiyong Zhu; Milad Rezvani; Jack Harbell; Aras N Mattis; Alan R Wolfe; Leslie Z Benet; Holger Willenbring; Sheng Ding
Journal:  Nature       Date:  2014-02-23       Impact factor: 49.962

View more
  9 in total

1.  Discarded Livers Find a New Life: Engineered Liver Grafts Using Hepatocytes Recovered From Marginal Livers.

Authors:  Basak E Uygun; Maria-Louisa Izamis; Maria Jaramillo; Yibin Chen; Gavrielle Price; Sinan Ozer; Martin L Yarmush
Journal:  Artif Organs       Date:  2016-11-08       Impact factor: 3.094

2.  Brain isoform glycogen phosphorylase as a novel hepatic progenitor cell marker.

Authors:  Yu-Wen Huang; Chien-Chang Chiu; Ja-Der Liang; Ling-Ling Chiou; Guan-Tarn Huang; Ming-Jiun Yu; Hsuan-Shu Lee
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

3.  Periodic acid‑Schiff staining method for function detection of liver cells is affected by 2% horse serum in induction medium.

Authors:  Hui Hui; Wenjun Ma; Jiejie Cui; Mengjia Gong; Yi Wang; Yuanyuan Zhang; Tongchuan He; Yang Bi; Yun He
Journal:  Mol Med Rep       Date:  2017-09-22       Impact factor: 2.952

4.  Liver tissue fragments obtained from males are the most promising source of human hepatocytes for cell-based therapies - Flow cytometric analysis of albumin expression.

Authors:  Karolina Ewa Zakrzewska; Anna Samluk; Agnieszka Wencel; Krzysztof Dudek; Dorota Genowefa Pijanowska; Krzysztof Dariusz Pluta
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

5.  Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators.

Authors:  Lijun Chen; Chunfeng Zhang; Lu Chen; Xiaojun Wang; Bingyu Xiang; Xiaoxing Wu; Yang Guo; Xiaozhou Mou; Li Yuan; Bo Chen; Jinfu Wang; Charlie Xiang
Journal:  Stem Cells Transl Med       Date:  2016-07-28       Impact factor: 6.940

6.  A pair of cell preservation solutions for therapy with human adipose tissue-derived mesenchymal stromal cells.

Authors:  Yasutaka Fujita; Masuhiro Nishimura; Natsuki Watanabe Komori; Tamaki Wada; Chikage Shirakawa; Taichi Takenawa; Osamu Sawamoto; Masako Doi
Journal:  Regen Ther       Date:  2020-01-16       Impact factor: 3.419

7.  Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA-455-3p through Suppression of p21-Activated Kinase-2.

Authors:  Qing Zhou; Tengfei Gu; Yong Zhang; Hongda Li; Xuemei Zhuansun; Sanrong Xu; Yuting Kuang
Journal:  Biomed Res Int       Date:  2021-02-25       Impact factor: 3.411

8.  R-spondin 1 and noggin facilitate expansion of resident stem cells from non-damaged gallbladders.

Authors:  Natalia Lugli; Irene Kamileri; Adrian Keogh; Thomas Malinka; Michalis E Sarris; Iannis Talianidis; Olivier Schaad; Daniel Candinas; Deborah Stroka; Thanos D Halazonetis
Journal:  EMBO Rep       Date:  2016-03-18       Impact factor: 8.807

9.  Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Guang-Peng Zhou; Yi-Zhou Jiang; Li-Ying Sun; Zhi-Jun Zhu
Journal:  Stem Cell Res Ther       Date:  2020-09-25       Impact factor: 6.832

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.